Wikstrand C J, Mahaley M S, Bigner D D
Cancer Res. 1977 Dec;37(12):4267-75.
The surface antigenic characteristics of human glial brain tumor (HGBT) cells were studied by complement-dependent cytotoxic antibody assays and indirect membrane immunofluorescence. Eight permanent, well-characterized cell lines derived from human gliomas were used for analysis with antisera raised by hyperimmunization of nonhuman primates (Macaca fascicularis) with glioblastoma multiforme tissue or established HGBT cells lines. Exhaustive absorption of these antisera to remove predominantly antispecies activity rendered HLA nonreactive "preabsorbed" antisera, which reacted with a large panel of gliomatous and nongliomatous human tumor cells; 1 carcinoma, 2 sarcomas, 2 melanomas, 1 neuroblastoma, and 8 HGBT cell lines. Four lymphoblastoid lines and 2 carcinomas were unreactive. After further absorption with a human osteogenic sarcoma cell line, the antisera demonstrated significant levels of reactivity for 8 tested HGBT cell lines and no longer reacted with the nongliomatous cultured tumor cells lines. Therefore, extensive absorption of nonhuman primate anti-human glioma sera removed all activity for the nongliomatous cell lines tested, but it left significant reactivity against a glial tumor cell line-associated antigen(s) present on all 8 human glioma cell lines tested.
通过补体依赖细胞毒性抗体测定和间接膜免疫荧光法研究了人胶质脑瘤(HGBT)细胞的表面抗原特性。使用从人胶质瘤中获得的8个特征明确的永久细胞系,用多形性胶质母细胞瘤组织或已建立的HGBT细胞系对非人灵长类动物(食蟹猴)进行超免疫制备的抗血清进行分析。用这些抗血清进行彻底吸收以去除主要的抗种属活性,得到与HLA无反应的“预吸收”抗血清,该抗血清可与大量胶质瘤和非胶质瘤人肿瘤细胞发生反应;1种癌、2种肉瘤、2种黑色素瘤、1种神经母细胞瘤和8种HGBT细胞系。4种淋巴母细胞系和2种癌无反应。用人骨肉瘤细胞系进一步吸收后,抗血清对8种测试的HGBT细胞系表现出显著的反应性,且不再与非胶质瘤培养肿瘤细胞系发生反应。因此,对非人灵长类抗人胶质瘤血清进行广泛吸收可消除对所有测试的非胶质瘤细胞系的活性,但对所有8种测试的人胶质瘤细胞系中存在的与胶质肿瘤细胞系相关的抗原仍保留显著反应性。